Xiang Chen
Guangzhou University of Chinese Medicine(CN)Central South University(CN)St. John's University(US)Guizhou University(CN)Shaoxing University(CN)Chinese Academy of Sciences(CN)Nantong University(CN)Affiliated Hospital of Nantong University(CN)SKiN Health(CA)Shanghai University of Traditional Chinese Medicine(CN)Second People's Hospital of NanTong(CN)Hunan Cancer Hospital(CN)Xiangya Hospital Central South University(CN)University of Chinese Academy of Sciences(CN)Ningbo Institute of Industrial Technology(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, Drug Transport and Resistance Mechanisms, RNA modifications and cancer
Most-Cited Works
- → Synthesis of a Novel Hydrazone Derivative and Biophysical Studies of Its Interactions with Bovine Serum Albumin by Spectroscopic, Electrochemical, and Molecular Docking Methods(2010)265 cited
- → A bis-Benzylidine Piperidone Targeting Proteasome Ubiquitin Receptor RPN13/ADRM1 as a Therapy for Cancer(2013)165 cited
- → A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis(2008)127 cited
- → LncRNA TUG1 sponges miR-145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis(2017)90 cited
- → The adsorption of an anticancer hydrazone by protein: an unusual static quenching mechanism(2011)84 cited
- → Investigating the interactions of a novel anticancer delocalized lipophilic cation and its precursor compound with human serum albumin(2014)34 cited